Best practice tools to build an integrated approach to multimorbidity

The traditional model of treating single diseases no longer works.

Data collected from 2016 to 2019 indicated that 32.9% of US adults had multiple chronic conditions—and that attempting to address these issues individually and separately is ineffective and costly. This fact is particularly poignant for Medicaid populations, who are significantly more likely to suffer from multimorbidity than non-Medicaid patients.

Multimorbidity disproportionately affects those with lower socioeconomic status and the elderly, impairing daily functioning, reducing quality of life, and severely impacting mental health. Further, multimorbidity of chronic conditions leads to poorer outcomes in patients and increases the burden of treatment and associated costs.

Medicaid plans and providers must take a proactive and comprehensive approach to patient care, but it’s easier said than done. In this blog post, get analytics-powered strategies and accompanying tools that can help you improve outcomes for the most at-risk members.

Strategies to improve member outcomes

1. Issue: Individuals living in areas of high socioeconomic deprivation develop multimorbidity 10-15 years earlier than those living in affluent areas.

Strategy: To understand and support their members, health plans must identify those living in areas of increased risk for overall socioeconomic vulnerability.

Tool: CDC/ATSDR Social Vulnerability Index > Examine member risk from all angles, including housing, transportation, and language barriers.

CDC/ATSDR Social Vulnerability index

2. Issue: When chronic diseases are addressed individually, patients often experience unnecessary suffering and mismanaged care.

Strategy: Health plans must implement integrated, multimorbidity care models that prioritize careful care coordination, self-management support for patients, and community support initiatives.

Tool: Multimorbidity Dashboards > Identify the top clusters for a given population, stratify by race/ethnicity, age, and socioeconomic risk, and drill down to patient-level detail to enable care management and facilitation programming.

Mental and physical health multimorbidity
Multimorbidity with moderate to high social vulnerability index (SVI)

3. Issue: Members with multiple chronic conditions often require polypharmacy—using multiple drugs to treat diseases and other health conditions—which is complex and can be dangerous. Previous studies have shown that approximately 20% of hospital readmissions can be medication-related and 70% of these readmissions are possibly preventable.

Strategy: Identify members with multiple chronic conditions who are currently prescribed four or more prescriptions.

Tool: Polypharmacy Dimensions Report > Keep close track of members’ prescription prevalence and disease development to avoid adverse effects of polypharmacy, such as falls, drug interactions, and drug-disease interactions.

Polypharmacy dimensions report

The importance of patient engagement

Using data to improve clinical outcomes is just one part of the care delivery equation in Medicaid. Another critical element is engaging members with their health and care needs.

To serve the Medicaid population effectively, plans need to get members in the door to access comprehensive care provided by empathetic clinicians, as well as resources to address fundamental barriers to health. Strong analytics platforms use data points to help health plans understand which members aren’t engaging in care, what barriers they are experiencing, and how to overcome those obstacles.

Analytics also offer health plans the ability to understand which providers have consistently higher member engagement or which are accepting a larger number of Medicaid members.

In conclusion

Multimorbidity is a complex, challenging issue facing millions of Americans—and their health plans. To address member needs holistically, Medicaid plans must apply data strategically, as data is only an effective tool when it can be used to drive action. At MedeAnalytics, our mission is to empower health plans with robust data analytics platforms and tools necessary to get their members the right care, from the right people, in the right place and at the right time.

Kathryn Burch

Kathryn Burch is a Public Sector Product Manager at MedeAnalytics delivering key insights into Medicaid beneficiary data. She has over 10 years of experience in Medicaid care delivery, health plan operations, quality improvement reporting, and interventions. Kathryn’s passion is helping plans understand cost drivers, identify gaps in care, and use demographic and SDOH data to improve care outcomes and maximize resources.

Get our take on industry trends

Crystal ball not necessary: predictive analytics helps health systems reduce denials

September 2, 2020

The idea of having a crystal ball to better understand what claims will be denied is an awesome concept. But one we can’t rely on. Thankfully, we have predictive analytics to take the place of a crystal ball.

Read on...

How did we get here? Hospital analytics and the new normal

July 15, 2020

I have heard the word “unprecedented” so many times in 2020 that it has lost its significance; many of us have become desensitized to the extraordinary changes in the world this year.

Read on...

How to help employer groups plan in a time of uncertainty

June 15, 2020

Employers and their sponsored health plans are thinking about next year’s benefit designs with a significant challenge not seen before: the effect of the coronavirus pandemic. There are important considerations to take into account before making any decisions about new or existing coverage. Becky Niehus, a director of Product Consulting at MedeAnalytics, explores these new issues and what employers can do to ensure employees are “covered.”

Read on...

Healthcare’s return to “normal” after COVID-19: Is it possible?

June 9, 2020

As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”

Read on...